|
|
.
See Category: Diseases of the musculoskeletal system and connective tissue
See Header: Rheumatoid lung disease with rheumatoid arthritis
ICD-10 (CM) Code and Descriptor
|
M05.19 |
Rheumatoid lung disease with rheumatoid arthritis of multiple sites
|
M0519 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 52.77%
|
16.49%
|
10.03%
|
5.54%
|
3.56%
|
2.37%
|
1.85%
|
1.19%
|
1.58%
|
0.79%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for M05.19*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
147
|
147
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
137
|
137
|
|
80053
|
COMPREHEN METABOLIC PANEL |
120
|
120
|
|
86140
|
C-REACTIVE PROTEIN |
102
|
102
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
75
|
75
|
|
85652
|
RBC SED RATE AUTOMATED |
73
|
73
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
68
|
68
|
|
96413
|
CHEMO IV INFUSION 1 HR |
62
|
62
|
|
96415
|
CHEMO IV INFUSION ADDL HR |
61
|
145
|
|
97530
|
THERAPEUTIC ACTIVITIES |
60
|
100
|
|
97110
|
THERAPEUTIC EXERCISES |
51
|
72
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
44
|
57
|
|
J2930
|
METHYLPREDNISOLONE INJECTION |
44
|
54
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
41
|
80
|
|
J0129
|
ABATACEPT INJECTION |
40
|
3,025
|
|
J7050
|
NORMAL SALINE SOLUTION INFUS |
33
|
49
|
|
97116
|
GAIT TRAINING THERAPY |
29
|
34
|
|
J9312
|
INJ., RITUXIMAB, 10 MG |
26
|
2,600
|
|
82565
|
ASSAY OF CREATININE |
25
|
25
|
|
85651
|
RBC SED RATE NONAUTOMATED |
22
|
22
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
M05.19 related to the following DRG Codes:
196-198
|
